Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Fischer

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2008
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancerM H Cullen, P Zatloukal, S Sörenson, et al.
The European Respiratory Journal|August 1, 2009
Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosisD B Scherf, H Dally, P Müller, et al.
Journal of the American Veterinary Medical Association|September 8, 2000
Hepatotoxicity of stanozolol in catsK R Harkin, L A Cowan, G A Andrews, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2014
Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancerD F Heigener, K M Deppermann, J V Pawel, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|July 1, 1992
Necropsy findings from Vietnamese potbellied pigs, 33 casesL W Pace, J M Kreeger, M A Miller, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|January 1, 1993
Pleuropneumonia in Missouri swineJ R Turk, W H Fales, C W Maddox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2011
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancerA Schmittel, M Sebastian, L Fischer von Weikersthal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2020
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancerD Planchard, N Reinmuth, S Orlov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2012
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT studyM Kreuter, J Vansteenkiste, J R Fischer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2011
Third CECOG consensus on the systemic treatment of non-small-cell lung cancerT Brodowicz, T Ciuleanu, J Crawford, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2008
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancerM H Cullen, P Zatloukal, S Sörenson, et al.
The European Respiratory Journal|August 1, 2009
Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosisD B Scherf, H Dally, P Müller, et al.
Journal of the American Veterinary Medical Association|September 8, 2000
Hepatotoxicity of stanozolol in catsK R Harkin, L A Cowan, G A Andrews, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2014
Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancerD F Heigener, K M Deppermann, J V Pawel, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|July 1, 1992
Necropsy findings from Vietnamese potbellied pigs, 33 casesL W Pace, J M Kreeger, M A Miller, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|January 1, 1993
Pleuropneumonia in Missouri swineJ R Turk, W H Fales, C W Maddox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2011
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancerA Schmittel, M Sebastian, L Fischer von Weikersthal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2020
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancerD Planchard, N Reinmuth, S Orlov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2012
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT studyM Kreuter, J Vansteenkiste, J R Fischer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2011
Third CECOG consensus on the systemic treatment of non-small-cell lung cancerT Brodowicz, T Ciuleanu, J Crawford, et al.
Pageof 11